News & Updates

Show Multimedia Only

Adjuvant nivolumab: a new SoC for resected oesophageal or GEJ cancer?

14 May 2021 by

In individuals with resected oesophageal or gastro-oesophageal junction (GEJ) cancer who have received neoadjuvant chemoradiotherapy (CRT), adjuvant nivolumab therapy demonstrated superior efficacy over placebo, according to the CheckMate 577 trial.

Adjuvant nivolumab: a new SoC for resected oesophageal or GEJ cancer?

14 May 2021

Mobile sensing monitors cancer patients’ behaviour, physiology to predict symptom burden

14 May 2021 by

Digital biomarkers collected by smartphones and wearable sensors may help detect behavioural and physiological changes signalling symptom burden in pancreatic cancer patients before and after surgery, according to a recent study.

Mobile sensing monitors cancer patients’ behaviour, physiology to predict symptom burden

14 May 2021

Anticoagulant use may exert unfavourable effects on bone health

14 May 2021

Individuals who use anticoagulants appear to have decreased bone density and quality—an effect that is seen with direct-acting oral anticoagulants (DOACs) but more pronounced with warfarin, a study reports.

Anticoagulant use may exert unfavourable effects on bone health

14 May 2021

Immunosuppressant withdrawal viable in lupus nephritis

14 May 2021

A recent study reports that it is feasible to discontinue immunosuppressive therapy in lupus nephritis patients who have been in remission for at least 3 years and on antimalarial therapy. In those who develop flares after withdrawal, remission can be recaptured with appropriate treatment.

Immunosuppressant withdrawal viable in lupus nephritis

14 May 2021

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Adjuvant nivolumab: a new SoC for resected oesophageal or GEJ cancer?

Adjuvant nivolumab: a new SoC for resected oesophageal or GEJ cancer?

Mobile sensing monitors cancer patients’ behaviour, physiology to predict symptom burden

Mobile sensing monitors cancer patients’ behaviour, physiology to predict symptom burden

Anticoagulant use may exert unfavourable effects on bone health

Anticoagulant use may exert unfavourable effects on bone health

Immunosuppressant withdrawal viable in lupus nephritis

Immunosuppressant withdrawal viable in lupus nephritis